Navigation Links
PTC Therapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Ataluren in Duchenne Muscular Dystrophy
Date:12/6/2012

>

PTC also is currently conducting ongoing open-label safety and tolerability studies of ataluren for patients who were in previous ataluren clinical trials for nmDMD in both the United States and Europe. The company has worldwide development and commercial rights for ataluren in all indications and territories. Ataluren is also being developed for nonsense mutation cystic fibrosis and PTC is in discussions with regulators regarding next steps.

About Conditional Approval
Conditional approval is granted based on a positive benefit/risk ratio in the available data which, while not yet comprehensive, indicate that the public health benefits of immediate availability of a medicine outweigh its risks. The company is given obligations to fulfill, such as the performance of further studies. The approval is renewed on a yearly basis until all obligations have been fulfilled, and is then converted from a conditional approval into a full approval. Conditional approvals can only be granted for medicines that satisfy an unmet medical need, meaning the medicine is intended to be used for a disease or condition for which no treatment is readily available, and it is therefore important that patients have early access to the medicine concerned.

About Duchenne Muscular Dystrophy (DMD)
Primarily affecting males, Duchenne muscular dystrophy (DMD) is a progressive muscle disorder caused by the lack of functional dystrophin protein. Dystrophin is critical to the structural stability of skeletal, diaphragm, and heart muscles. Patients with Duchenne muscular dystrophy, the more severe form of the disorder, lose the ability to walk as early as age 10 and experience life-threatening lung and heart complications in their late teens and twenties. There are an estimated 35,000 patients with DMD in the United States and Europe and approximately 13 percent of all DMD cases are caused by nonsense mutations in the dystrophin gene. More information about DMD is available th
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech Ltd. ... of biopharmaceutical products in China ... subsidiary company of Sinovac, obtained the Certificate of ... from the China State and Food Administration (CFDA) ... production plants, and its Changping filing and packaging ...
(Date:5/23/2013)... Inc. (Vanda) (NASDAQ: VNDA ) today announced that ... of the Year by the Tech Council of ... 25 th Annual Tech Awards Celebration held in ... the leaders and innovators in the technology and life science ... regions. "We are deeply honored to receive ...
(Date:5/23/2013)...  Haemonetics Corporation (NYSE: HAE ) announced today ... Development, will present at The Deutsche Bank 38 th ... on May 29, 2013 at 1:30pm Eastern time.  ... The public may access Mr. Lindop,s presentation live via webcast ... Haemonetics (NYSE: HAE ) is a global ...
Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... a leader in unified RIS/PACS, Avreo continues to reinvent ... at RSNA.  Version 7 represents an extensive platform change ... , All new modern design with focus on workflow ... support, including Windows®, Mac OS® X, Apple® iOS, and ...
... 2011  Attendees of this week,s Radiological Society of North ... to see the latest addition to FUJIFILM Medical Systems ... medical informatics solutions. Fujifilm,s Synapse ® PACS 4.0 ... further maximize the user experience and improve overall efficiency.  ...
Cached Medicine Technology:Avreo Previews Version 7 RIS/PACS at RSNA 2Fujifilm Demonstrates the Latest Advancements of Synapse® PACS at RSNA 2Fujifilm Demonstrates the Latest Advancements of Synapse® PACS at RSNA 3
(Date:5/25/2013)... 25, 2013 The report “Global ... Types, Functions, Applications, Ingredients, Shell Materials, Packaging, & ... global food encapsulation market with analysis and forecasting ... also identifies the driving and restraining factors for ... trends, opportunities, and challenges. The market is segmented ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Studies from ... who are carrying excessive weight and their inability to ... many, simply losing weight can naturally relieve many symptoms. ... that improvement in sleep quality was significantly associated with ... month study dated November 6th, 2012, researchers ...
(Date:5/25/2013)... City Center, FL (PRWEB) May 25, 2013 ... is one of many of the NALA’s businesses throughout the ... Craig Amshel chose to participate in the nationwide event as ... as a Lieutenant Colonel in the Army. He said, “I ... in the community I serve, but I live here too.” ...
(Date:5/25/2013)... Pradaxa lawsuits filed on behalf ... bleeding while using the blood thinner continue to mount in ... of Illinois, Bernstein Liebhard LLP reports. According to a ... had been filed in the litigation as of ... by the Court on May 15th. ( In Re: Pradaxa ...
(Date:5/25/2013)... May 25, 2013 By working diligently ... declared the integration of the 2012 Lamborghini Aventador into ... the latest entrant in the list of vehicles lined ... vehicle is all set to thrill automobile lovers in ... power and spectacular looks, the 2012 Lamborghini Aventador comes ...
Breaking Medicine News(10 mins):Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2
... November is both Pancreatic Cancer Awareness Month and ... (NYBC) and its divisions in Manhattan, Long Island, Hudson ... community to join the fight against cancer by donating ... blood, and cancer patients may require frequent blood transfusions ...
... Daisy Martinez pleaded guilty today in U.S. District Court ... the Medicare program, Assistant Attorney General Lanny A. Breuer ... the Eastern District of Michigan; Andrew G. Arena, Special ... and Daniel R. Levinson, Inspector General of the Department ...
... the Melbourne Cup, Australia,s most prestigious and coveted horse race ... Melbourne Cup, and "Subbie" to several generations of Australian schoolchildren, ... quick actions of a "fairy godmother" from the United States, ... her pioneering efforts in the rice bran industry, flew to ...
... Ga., Oct. 30 CeloNova BioSciences today announced ... Notified Body a request for approval of its ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20081007/CLTU035-b ) ... Embozene(TM) Color-Advanced Microspheres are spherical embolics approved in ...
... while there are few new drugs in pipeline , ... antibiotic-resistant bacteria continues to present a major public health ... largest infectious diseases meetings Friday. , Chief among the ... to be infecting younger and otherwise healthier people. The ...
... ... insurers are denying discrimination against Swine Flu victims but when LSM Insurance recently called to ... ... not cover recent swine flu victims. Since July independent Canadian life insurance broker Lorne S. ...
Cached Medicine News:Health News:Community Blood Drives Benefit Cancer Patients 2Health News:Detroit Clinic Owner Pleads Guilty in Medicare Fraud Scheme 2Health News:Detroit Clinic Owner Pleads Guilty in Medicare Fraud Scheme 3Health News:Detroit Clinic Owner Pleads Guilty in Medicare Fraud Scheme 4Health News:Health of Subzero, 1992 Winner of Melbourne Cup, Threatened After Customs Mix Up 2Health News:Health of Subzero, 1992 Winner of Melbourne Cup, Threatened After Customs Mix Up 3Health News:CeloNova First to Produce Super-Sized Embolic Microsphere 2Health News:Antibiotic Resistance Still a Major Public Health Threat 2Health News:Antibiotic Resistance Still a Major Public Health Threat 3Health News:Antibiotic Resistance Still a Major Public Health Threat 4Health News:Life Insurance Firms Refusing to Insure Swine Flu Victims says major Canadian insurance broker 2
Full automatic, ready-to-use strip washer....
... Designed and manufactured ... the MultiWash II delivers ... you demand. The MultiWash ... with dependable accuracy, while ...
... 1983, Tosoh Corporation launched the first generation ... The HPLC/723Ghb brought a new level of ... the forefront of diabetes testing in Japan. ... generation system, the G7 offers advanced automation; ...
... CELL-DYN WorkCell delivers complete hematology automation to ... A modular configuration provides the flexibility to ... includes one Navigator module, one Load module, ... code reader. The basic system will incorporate ...
Medicine Products: